Astrana Financial Statements From 2010 to 2024

ASTH Stock   43.25  0.39  0.91%   
Astrana Health financial statements provide useful quarterly and yearly information to potential Astrana Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Astrana Health financial statements helps investors assess Astrana Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Astrana Health's valuation are summarized below:
Gross Profit
199.5 M
Profit Margin
0.0363
Market Capitalization
B
Enterprise Value Revenue
1.2193
Revenue
1.7 B
We have found one hundred twenty available fundamental signals for Astrana Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Astrana Health prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 1 B. Enterprise Value is estimated to decrease to about 1 B

Astrana Health Total Revenue

1.46 Billion

Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 16.9 M, Other Operating Expenses of 1.4 B or Operating Income of 88.8 M, as well as many indicators such as Price To Sales Ratio of 1.33, Dividend Yield of 0.0428 or PTB Ratio of 4.22. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.
  
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Astrana Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets980 M933.4 M424 M
Slightly volatile
Other Current Liabilities193.3 M184.1 M59.7 M
Slightly volatile
Total Current Liabilities229.6 M218.7 M76.2 M
Slightly volatile
Accounts Payable9.5 M9.1 MM
Slightly volatile
Cash308.5 M293.8 M112 M
Slightly volatile
Cash And Short Term Investments311.1 M296.3 M128.7 M
Slightly volatile
Common Stock Total Equity30 K54 K31.4 K
Slightly volatile
Common Stock Shares Outstanding49.4 M47.1 M27.4 M
Slightly volatile
Liabilities And Stockholders Equity980 M933.4 M424.1 M
Slightly volatile
Non Current Liabilities Total319.1 M303.9 M116.8 M
Slightly volatile
Other Stockholder Equity389.6 M371 M151.1 M
Slightly volatile
Total Liabilities548.7 M522.6 M193 M
Slightly volatile
Total Current Assets484.6 M461.5 M187.5 M
Slightly volatile
Common Stock33.4 K54 K34.8 K
Slightly volatile
Short and Long Term Debt Total337.1 M321 M110.2 M
Slightly volatile
Short Term Debt26 M24.8 M6.6 M
Slightly volatile
Property Plant And Equipment Net23.8 M44.6 M24.7 M
Slightly volatile
Non Current Assets Total495.4 M471.9 M236.5 M
Slightly volatile
Non Currrent Assets Other46.9 M44.6 M8.6 M
Slightly volatile
Net Receivables155.1 M147.8 M51.6 M
Slightly volatile
Other Current Assets18.3 M17.4 M7.2 M
Slightly volatile
Property Plant And Equipment Gross70.8 M67.4 M29.3 M
Slightly volatile
Current Deferred Revenue706.8 K744 K3.7 M
Slightly volatile
Long Term Debt271.9 M258.9 M94 M
Slightly volatile
Good Will139.8 M278.8 M119.4 M
Slightly volatile
Long Term Debt Total245.6 M233.9 M90 M
Slightly volatile
Capital Surpluse434.8 M414.1 M157.1 M
Slightly volatile
Intangible Assets56.4 M71.6 M44.8 M
Slightly volatile
Property Plant Equipment155.7 M148.3 M40.4 M
Slightly volatile
Other Liabilities28.2 M21 M27.3 M
Very volatile
Short and Long Term Debt20.5 M19.5 M6.6 M
Slightly volatile
Long Term Investments38.4 M32.2 M27.7 M
Slightly volatile
Non Current Liabilities Other3.4 M3.6 M12.3 M
Slightly volatile
Warrants11.7 M12.3 M131.9 M
Slightly volatile
Capital Lease Obligations44.7 M42.6 M11.4 M
Slightly volatile
Net Invested Capital573.9 M892.7 M358.9 M
Slightly volatile
Net Working Capital219.5 M242.8 M123.9 M
Slightly volatile
Capital Stock46.1 K54 K38.8 K
Slightly volatile

Astrana Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses1.4 B1.3 B413.7 M
Slightly volatile
Selling General Administrative118.2 M112.6 M36.6 M
Slightly volatile
Total Revenue1.5 B1.4 B448.5 M
Slightly volatile
Cost Of Revenue1.2 B1.2 B371.8 M
Slightly volatile
Depreciation And Amortization8.9 M17.7 M9.2 M
Slightly volatile
Gross Profit225.7 M215 M76.7 M
Slightly volatile
Minority Interest2.7 M2.9 M12.9 M
Slightly volatile
Interest Income14.9 M14.2 M3.1 M
Slightly volatile
Non Recurring539.2 K567.6 K2.1 M
Slightly volatile
Reconciled Depreciation14.7 M17.7 M18.4 M
Slightly volatile
Extraordinary Items7.8 M8.7 M9.5 M
Slightly volatile

Astrana Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow302.4 M288 M92.1 M
Slightly volatile
End Period Cash Flow308.9 M294.2 M111.6 M
Slightly volatile
Depreciation8.9 M17.7 M9.2 M
Slightly volatile
Stock Based Compensation23.1 M22 M5.7 M
Slightly volatile
Dividends Paid65.2 M62.1 M21.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.331.30621.3196
Slightly volatile
Dividend Yield0.04280.03430.029
Slightly volatile
PTB Ratio4.222.94884.358
Slightly volatile
Days Sales Outstanding34.2138.891637.4872
Slightly volatile
Book Value Per Share8.268.79497.4847
Slightly volatile
Stock Based Compensation To Revenue0.00960.01590.0099
Slightly volatile
Capex To Depreciation1.691.60740.7052
Slightly volatile
PB Ratio4.222.94884.358
Slightly volatile
EV To Sales1.31.32581.2063
Slightly volatile
Payables Turnover13612951.834
Slightly volatile
Sales General And Administrative To Revenue0.05430.08120.0498
Slightly volatile
Capex To Revenue0.02160.02060.0094
Slightly volatile
Cash Per Share4.276.34414.0393
Slightly volatile
Days Payables Outstanding2.692.82715.3218
Slightly volatile
Income Quality1.061.17940.9753
Slightly volatile
Intangibles To Total Assets0.260.37550.2489
Slightly volatile
Current Ratio2.022.11052.172
Slightly volatile
Tangible Book Value Per Share1.231.29082.9563
Slightly volatile
Receivables Turnover10.519.385110.6529
Slightly volatile
Graham Number9.8819.612910.2746
Slightly volatile
Shareholders Equity Per Share13.8113.15095.9022
Slightly volatile
Debt To Equity0.340.45330.2604
Slightly volatile
Capex Per Share0.640.61080.1841
Slightly volatile
Average Receivables46.8 M70.4 M51.9 M
Slightly volatile
Revenue Per Share31.1729.689514.9855
Slightly volatile
Interest Debt Per Share6.626.30642.4945
Slightly volatile
Debt To Assets0.310.29830.1176
Slightly volatile
Operating Cycle34.2138.891637.4872
Slightly volatile
Price Book Value Ratio4.222.94884.358
Slightly volatile
Days Of Payables Outstanding2.692.82715.3218
Slightly volatile
Ebt Per Ebit1.161.06181.1406
Slightly volatile
Effective Tax Rate0.30.35610.2244
Slightly volatile
Company Equity Multiplier2.861.51962.904
Slightly volatile
Long Term Debt To Capitalization0.250.29660.1781
Slightly volatile
Total Debt To Capitalization0.20.31190.1586
Slightly volatile
Debt Equity Ratio0.340.45330.2604
Slightly volatile
Quick Ratio2.022.11052.172
Slightly volatile
Cash Ratio1.181.34361.354
Slightly volatile
Days Of Sales Outstanding34.2138.891637.4872
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.960.58190.9747
Slightly volatile
Price To Book Ratio4.222.94884.358
Slightly volatile
Fixed Asset Turnover25.0631.114127.3104
Slightly volatile
Debt Ratio0.310.29830.1176
Slightly volatile
Price Sales Ratio1.331.30621.3196
Slightly volatile
Asset Turnover1.211.48571.4649
Slightly volatile
Gross Profit Margin0.20.1550.1932
Slightly volatile
Price Fair Value4.222.94884.358
Slightly volatile

Astrana Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market CapB1.8 B719.9 M
Slightly volatile
Enterprise ValueB1.8 B758.6 M
Slightly volatile

Astrana Fundamental Market Drivers

Cash And Short Term Investments296.3 M

About Astrana Health Financial Statements

Investors use fundamental indicators, such as Astrana Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue744 K706.8 K
Total Revenue1.4 B1.5 B
Cost Of Revenue1.2 B1.2 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.08  0.05 
Capex To Revenue 0.02  0.02 
Revenue Per Share 29.69  31.17 
Ebit Per Revenue 0.06  0.05 

Currently Active Assets on Macroaxis

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
1.3
Revenue Per Share
36.415
Quarterly Revenue Growth
0.375
Return On Assets
0.0449
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.